The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Precision in Time: Delivering Results in Urgency o The world handed our industry an urgent and paramountly important need for precise medicine, with considerably zero warning. When the COVID-19 pandemic reached the world and became more than a regional concern, life as we knew it came to a screeching halt, lives were lost at unprecedented rates, and many more were at risk every day. Within the Pharmaceutical Industry, we had an Urgent need to deliver precision in time. The COVID-19 Vaccine was developed, tested, and available for global public use faster than any other vaccine, or drug product, in history. This presentation dives into some of the background, development tactics, project management, and the facilities of the future, that tie together to prepare our industry for the next Urgent need, the next pandemic, and the next vaccine that will help save countless lives.
Speaker(s):
Andrea
M. Uvanni,
The Moirae Group CEO, Principal Consultant,
The Moirae Group
Amy
A. Weaver,
Associate Director, Biobank Lead,
Moderna TX
You must be logged in and own this session in order to
post comments.